Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Movectro, cladribine tablets
Also known as: Mylinax
print preview
bookmark
share with colleague
General Information
Company
Merck KGaA
Description
Purine nucleoside analog that inhibits DNA synthesis
Molecular Target
DNA polymerase
Mechanism of Action
DNA synthesis inhibitor
Latest Stage of Development
Approved
Indication
Multiple sclerosis (MS)
Partner
Teva Pharmaceutical Industries Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information